Posted by Michael Wonder on 24 May 2021
Swiss pharma industry fights lower drug prices in the US
24 May 2021 - A proposed law currently under discussion in the United States Congress aims to lower prescription drug prices. But Big Pharma, including Swiss giants Roche and Novartis, are pulling out all the stops to lobby against the measure.
The issue often sparks heated debate across the Atlantic. The cost of prescription drugs in the US is among the highest in the world, with many Americans regularly forced to bleed themselves dry just to pay their pharmaceutical bills. Written in 2019 and dusted off last April, draft legislation to reform the law is currently being discussed by Congress. It’s a move that has not gone unnoticed by Big Pharma, with the industry’s giants — including the Swiss — discretely trying to put an end to the measure.
